FDA studying if gel for diabetic ulcers causes cancer

March 31, 2008

Regranex is being studied by the FDA on whether it is linked to higher rates of cancer.

Is Regranex (becaplermin, Johnson & Johnson) Gel, which helps heal foot and leg diabetic ulcers, associated with higher rates of cancer death? That?s what the Food & Drug Administration is now studying. In an early company.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, clickhere.